Article

The complex G protein-coupled receptor kinase 2 (GRK2) interactome unveils new physiopathological targets

Departamento de Biología Molecular and Centro de Biología Molecular Severo Ochoa (Consejo Superior de Investigaciones Científicas-Universidad Autónoma de Madrid), Universidad Autónoma, Madrid, Spain.
British Journal of Pharmacology (Impact Factor: 4.99). 06/2010; 160(4):821-32. DOI: 10.1111/j.1476-5381.2010.00727.x
Source: PubMed

ABSTRACT GRK2 is a ubiquitous member of the G protein-coupled receptor kinase (GRK) family that appears to play a central, integrative role in signal transduction cascades. GRKs participate together with arrestins in the regulation of G protein-coupled receptors (GPCR), a family of hundreds of membrane proteins of key physiological and pharmacological importance, by triggering receptor desensitization from G proteins and GPCR internalization, and also by helping assemble macromolecular signalosomes in the receptor environment acting as agonist-regulated adaptor scaffolds, thus contributing to signal propagation. In addition, emerging evidence indicates that GRK2 can phosphorylate a growing number of non-GPCR substrates and associate with a variety of proteins related to signal transduction, thus suggesting that this kinase could also have diverse 'effector' functions. We discuss herein the increasing complexity of such GRK2 'interactome', with emphasis on the recently reported roles of this kinase in cell migration and cell cycle progression and on the functional impact of the altered GRK2 levels observed in several relevant cardiovascular, inflammatory or tumour pathologies. Deciphering how the different networks of potential GRK2 functional interactions are orchestrated in a stimulus, cell type or context-specific way is critical to unveil the contribution of GRK2 to basic cellular processes, to understand how alterations in GRK2 levels or functionality may participate in the onset or development of several cardiovascular, tumour or inflammatory diseases, and to assess the feasibility of new therapeutic strategies based on the modulation of the activity, levels or specific interactions of GRK2.

Download full-text

Full-text

Available from: Catalina Ribas, Jun 30, 2015
1 Follower
 · 
224 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The ADRBK1 gene, which transcribes the G protein-coupled receptor kinase 2 (GRK2), is an important regulator of adrenergic signaling and plays a central role in heart failure pathology. Nearly 45% of black Americans have high blood pressure. The prevalence of hypertension and the severity of cardiovascular morbidity are greater in blacks than other racial groups. Regulatory single-nucleotide polymorphisms (rSNPs) in the promoter region (rs12286664 and -703bp), introns (rs1894111, rs7128315 and rs948988) and 3' UTR (rs4370946) of the ADRBK1 gene are in linkage disequilibrium in the black population. These rSNP alleles alter the DNA landscape resulting in changes in transcriptional factor binding sites (TFBS). The alleles of each rSNP were found to produce unique TFBS resulting in potential changes in ADRBK1 regulation. These regulatory changes are discussed with respect to cardiovascular disease in the black population. Cite this article as: Buroker, N.E, ADRBK1 (GRK2) rSNPs, transcriptional factor binding sites and cardiovascular disease in the Black population. JCvD 2014:in press
    Journal of cardiovascular disease research 02/2014;
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: G protein-coupled receptor kinase 2 (GRK2) is a relevant signaling node of the cellular transduction network, playing major roles in the physiology of various organs/tissues including the heart and blood vessels. Emerging evidence suggests that GRK2 is up regulated in pathological situations such as heart failure, hypertrophy and hypertension, and its inhibition offers a potential therapeutic solution to these diseases. We explored the GRK2 inhibitory activity of a library of cyclic peptides derived from the HJ loop of G protein-coupled receptor kinases 2 (GRK2). The design of these cyclic compounds was based on the conformation of the HJ loop within the X-ray structure of GRK2. One of these compounds, the cyclic peptide 7, inhibited potently and selectively the GRK2 activity, being more active than its linear precursor. In a cellular system, this peptide confirms the beneficial signaling properties of a potent GRK2 inhibitor. Preferred conformations of the most potent analog were investigated by NMR spectroscopy.
    European Journal of Medicinal Chemistry 09/2013; 69C:384-392. DOI:10.1016/j.ejmech.2013.08.039 · 3.43 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: G-protein-coupled receptor kinase 2 (GRK2) levels are elevated in inflammation but its role is not clear yet. Here we show that GRK2 expression is dependent on NFκB transcriptional activity. In macrophages, LPS induces GRK2 accumulation in mitochondria increasing biogenesis. The overexpression of the carboxy-terminal domain of GRK2 (βARK-ct), known to displace GRK2 from plasma membranes, induces earlier localization of GRK2 to mitochondria in response to LPS leading to increased mt-DNA transcription and reduced ROS production and cytokine expression. Our study shows the relevance of GRK2 subcellular localization in macrophage biology and its potential therapeutic properties in inflammation.
    FEBS letters 09/2013; 587(21). DOI:10.1016/j.febslet.2013.09.002 · 3.34 Impact Factor